Premier Fund Managers’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-22,748
Closed -$437K 178
2025
Q2
$437K Buy
22,748
+2,522
+12% +$44.8K 0.02% 151
2025
Q1
$363K Buy
+20,226
New +$436K 0.01% 165
2022
Q4
Sell
-43,374
Closed -$742K 204
2022
Q3
$742K Hold
43,374
0.06% 124
2022
Q2
$957K Hold
43,374
0.04% 172
2022
Q1
$1.64M Hold
43,374
0.06% 168
2021
Q4
$1.96M Sell
43,374
-32,358
-43% -$1.69M 0.06% 157
2021
Q3
$4.59M Hold
75,732
0.15% 143
2021
Q2
$7.18M Sell
75,732
-20,576
-21% -$1.64M 0.24% 106
2021
Q1
$6.06M Buy
+96,308
New +$7.48M 0.23% 109

Other funds holding CDNA

Premier Fund Managers's CDNA Position: Q3 2025 in Review

Premier Fund Managers sold out of CareDx (CDNA) in Q3 2025, closing a stake of 22,748 shares — an estimated $437K sold.

Premier Fund Managers first reported a position in CDNA in Q1 2021 and held it in 9 quarters. The position peaked at $7.18M in Q2 2021. 187 funds tracked by Wall St. Rank hold CDNA as of Q3 2025.

  • Premier Fund Managers reported no remaining CareDx position as of Q3 2025 after selling out during the quarter.
  • Premier Fund Managers sold 22,748 CareDx shares in Q3 2025, an estimated $437K.
  • Premier Fund Managers first reported a position in CareDx in Q1 2021 and held it in 9 quarters.
  • Premier Fund Managers's CareDx position peaked at $7.18M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held CareDx as of Q3 2025.

Based on Premier Fund Managers's 13F filing for Q3 2025, filed 10 Nov 2025.